Form D · Venture Capital Fund

Medical Excellence Capital Partners, LP

Nissequogue, NY · CIK 0001823093

Offering snapshot reported Sep 2, 2022 · SEC filing

Reported sold: $146M
Investors reported: 12
Minimum accepted: $1
First sale: Nov 19, 2020

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$114,400,000 → $145,650,000
Reported investors8 → 12

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 2, 2022	Amendment	$145,650,000	$31,250,000vs Mar 16, 2022	12	SEC filing
Mar 16, 2022	Amendment	$114,400,000	$14,400,000vs Nov 19, 2020	8	SEC filing
Nov 19, 2020	Initial	$100,000,000	No comparison	1	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06b, 3C, 3C.1, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0 (estimated)
Form D file number: 021-381032

Source: Form D, filed Sep 2, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A Ict Holding, Ltd.	Promoter
N/A Medical Excellence Capital, Llc	Executive
N/A Medical Excellence Gp, Llc	Director, Executive
John Prufeta	Executive, Promoter
N/A Siracusa Holdings, Llc	Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

C/O Medical Excellence Capital, Llc 335 Old Mill Road
Nissequogue, NY, 11780